These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16325717)

  • 1. Apraclonidine and LASIK.
    Aslanides IM; Tsiklis NS; Pallikaris IG; Jankov MR; Coskunseven E; Ozkilic E
    Ophthalmology; 2005 Dec; 112(12):2238; author reply 2244. PubMed ID: 16325717
    [No Abstract]   [Full Text] [Related]  

  • 2. Early flap dislocation with perioperative brimonidine use in laser in situ keratomileusis.
    Nowroozzadeh MH
    J Cataract Refract Surg; 2010 Feb; 36(2):368. PubMed ID: 20152647
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of topical apraclonidine on subconjunctival hemorrhage and flap adherence in LASIK patients.
    Aslanides lM; Tsiklis NS; Ozkilic E; Coskunseven E; Pallikaris lG; Jankov MR
    J Refract Surg; 2006 Jun; 22(6):585-8. PubMed ID: 16805122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prophylactic brimonidine on bleeding complications and flap adherence after laser in situ keratomileusis.
    Norden RA
    J Refract Surg; 2002; 18(4):468-71. PubMed ID: 12160159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical phenylephrine in laser in situ keratomileusis.
    Issa AF
    J Cataract Refract Surg; 2007 Feb; 33(2):355-6. PubMed ID: 17276291
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of prophylactic topical brimonidine (0.15%) administration on the development of subconjunctival hemorrhage after intravitreal injection.
    Kim CS; Nam KY; Kim JY
    Retina; 2011 Feb; 31(2):389-92. PubMed ID: 20890238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
    Salib GM; McDonald MB; Smolek M
    J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of anterior-segment vascularity with preoperative topical apraclonidine 1%.
    Sii F; Todd B; Shah P; Chiang M
    J Cataract Refract Surg; 2006 Apr; 32(4):692-3. PubMed ID: 16698500
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of Epi-LASIK and off-flap Epi-LASIK for the treatment of low and moderate myopia.
    Kalyvianaki MI; Kymionis GD; Kounis GA; Panagopoulou SI; Grentzelos MA; Pallikaris IG
    Ophthalmology; 2008 Dec; 115(12):2174-80. PubMed ID: 19041475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More than just an ocular solution.
    Pekdemir M; Yanturali S; Karakus G
    Emerg Med J; 2005 Oct; 22(10):753-4. PubMed ID: 16189050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic brimonidine before LASIK.
    Uretmen O; Ates H; Andaç K
    J Refract Surg; 2003; 19(5):612. PubMed ID: 14518756
    [No Abstract]   [Full Text] [Related]  

  • 12. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
    Unal M; Yücel I; Akar Y
    J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of apraclonidine versus dorzolamide on intraocular pressure after phacoemulsification.
    Onal S; Gozum N; Gucukoglu A
    Ophthalmic Surg Lasers Imaging; 2005; 36(6):457-62. PubMed ID: 16355950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prophylactic brimonidine instillation on bleeding during strabismus surgery in adults.
    Hong S; Kim CY; Seong GJ; Han SH
    Am J Ophthalmol; 2007 Sep; 144(3):469-70. PubMed ID: 17765438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of 0.5% apraclonidine solution in evaluation of blepharoptosis.
    Yazici B; Beden U
    Ophthalmic Plast Reconstr Surg; 2008; 24(4):299-301. PubMed ID: 18645436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subconjuctival hemorrhages after LASIK. Laser in situ keratomileusis.
    Dada T; Sharma N; Vaypayee RB; Dada VK
    J Cataract Refract Surg; 2000 Nov; 26(11):1570-1. PubMed ID: 11185595
    [No Abstract]   [Full Text] [Related]  

  • 17. Exposure to topical apraclonidine in children with glaucoma.
    Wright TM; Freedman SF
    J Glaucoma; 2009; 18(5):395-8. PubMed ID: 19525731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of brimonidine tartrate 0.2% ophthalmic solution in reducing halos after laser in situ keratomileusis.
    Lee JH; You YS; Choe CM; Lee ES
    J Cataract Refract Surg; 2008 Jun; 34(6):963-7. PubMed ID: 18499002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence and risk factors for developing dry eye after myopic LASIK.
    De Paiva CS; Chen Z; Koch DD; Hamill MB; Manuel FK; Hassan SS; Wilhelmus KR; Pflugfelder SC
    Am J Ophthalmol; 2006 Mar; 141(3):438-45. PubMed ID: 16490488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laser in situ keratomileusis versus surface ablation: visual outcomes and complications.
    Ghadhfan F; Al-Rajhi A; Wagoner MD
    J Cataract Refract Surg; 2007 Dec; 33(12):2041-8. PubMed ID: 18053901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.